Clinical trials that explore long-term endpoints may confound the analysis when post-study therapy effects are considered. This article introduces a procedure to mediate the effects of confounding and allow inferences of first-line experimental treatments in the presence of post-study therapy. The procedure is evaluated by intensive simulation analyses and applied to an analysis of a clinical cancer trial.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1080/10543406.2015.1074916 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!